Postoperative radiotherapy for elderly patients with stage III lung cancer
作者： Juan P. Wisnivesky , Ethan A. Halm , Marcelo Bonomi , Cardinale Smith , Grace Mhango
DOI: 10.1002/CNCR.26585
关键词: Internal medicine 、 Lung cancer 、 Propensity score matching 、 Population 、 Cancer 、 Radiation therapy 、 Medicine 、 Retrospective cohort study 、 Hazard ratio 、 Cohort 、 Surgery
摘要: BACKGROUND: The potential role of postoperative radiation therapy (PORT) for patients who have completely resected, stage III nonsmall cell lung cancer (NSCLC) with N2 disease …
elsevier.com
sci-hub.se 参考文章(39)
Craig C. Earle, Jerry S. Tsai, Richard D. Gelber, Milton C. Weinstein, Peter J. Neumann, Jane C. Weeks, Effectiveness of Chemotherapy for Advanced Lung Cancer in the Elderly: Instrumental Variable and Propensity Analysis Journal of Clinical Oncology. ,vol. 19, pp. 1064- 1070 ,(2001) , 10.1200/JCO.2001.19.4.1064
Richard L. Kalish, Jennifer Daley, Charles C. Duncan, Roger B. Davis, Gerald A. Coffman, Lisa I. Iezzoni, Costs of Potential Complications of Care for Major Surgery Patients American Journal of Medical Quality. ,vol. 10, pp. 48- 54 ,(1995) , 10.1177/0885713X9501000108
Carrie N Klabunde, Arnold L Potosky, Julie M Legler, Joan L Warren, Development of a comorbidity index using physician claims data. Journal of Clinical Epidemiology. ,vol. 53, pp. 1258- 1267 ,(2000) , 10.1016/S0895-4356(00)00256-0
M. Gail, T. H. Weisenburger, Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The lung cancer study group The New England Journal of Medicine. ,vol. 315, pp. 1377- 1381 ,(1986)
James A. Bonner, The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity. Cancer. ,vol. 86, pp. 195- 196 ,(1999) , 10.1002/(SICI)1097-0142(19990715)86:2<195::AID-CNCR1>3.0.CO;2-B
RJ Stephens, , DJ Girling, NM Bleehen, K Moghissi, HMA Yosef, D Machin, The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. British Journal of Cancer. ,vol. 74, pp. 632- 639 ,(1996) , 10.1038/BJC.1996.413
Yan Xu, Hongyu Liu, Jun Chen, Qinghua Zhou, Comparisons between the National Comprehensive Cancer Network (NCCN) non‐small‐cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009 Thoracic Cancer. ,vol. 1, pp. 83- 86 ,(2010) , 10.1111/J.1759-7714.2010.00016.X
Ramón Rami-Porta, Vanessa Bolejack, John Crowley, David Ball, Jhingook Kim, Gustavo Lyons, Thomas Rice, Kenji Suzuki, Charles F Thomas Jr, William D Travis, Yi-Long Wu, Prognostic Factors Committee, None, The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer Journal of Thoracic Oncology. ,vol. 2, pp. 990- 1003 ,(2007) , 10.1097/JTO.0B013E31811F4703
Mitchell Machtay, Jason H. Lee, Joseph B. Shrager, Larry R. Kaiser, Eli Glatstein, Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non–Small-Cell Lung Carcinoma Journal of Clinical Oncology. ,vol. 19, pp. 3912- 3917 ,(2001) , 10.1200/JCO.2001.19.19.3912
S Burdett, MKB Parmar, LA Stewart, RL Souhami, R Arriagada, DJ Girling, JP Pignon, V Torri, AH Brichet, JJ Lafitte, B Dautzenberg, M Debevec, V Kovac, RJ Stephens, A Gregor, S Piantadosi, P Rocmans, Paul Van Houtte, M Wang, Postoperative radiotherapy in nonsmall-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials The Lancet. ,vol. 352, pp. 257- 263 ,(1998) , 10.1016/S0140-6736(98)06341-7